Capula Management’s Acadia Healthcare ACHC Stock Holding History

Capula Management’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,440	Closed	-$201K	–	675
2022 Q4	$201K	Buy	+2,440	New	+$201K	﹤0.01%	695

Other funds holding ACHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Capula Management's ACHC Position: Q1 2023 in Review

Capula Management sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 2,440 shares — an estimated $201K sold.

Capula Management first reported a position in ACHC in Q4 2022 and held it in 1 quarter. The position peaked at $201K in Q4 2022. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

Capula Management reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
Capula Management sold 2,440 Acadia Healthcare shares in Q1 2023, an estimated $201K.
Capula Management first reported a position in Acadia Healthcare in Q4 2022 and held it in 1 quarter.
Capula Management's Acadia Healthcare position peaked at $201K in Q4 2022.
310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on Capula Management's 13F filing for Q1 2023, filed 10 May 2023.